Different responses of the blockade of the P2Y1 receptor with BPTU in human and porcine intestinal tissues and in cell cultures
Sara Traserra(Universitat Autònoma de Barcelona), Marcel Jiménez(Universitat Autònoma de Barcelona), Jane Maclnnes(University of Strathclyde), Margaret Cunningham(University of Bristol), Anna Accarino(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Charles Kennedy(Georgetown University), Lucía Relea, Patri Vergara(Universitat Autònoma de Barcelona), Claudia Barber(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Lewis C. MacPherson(University of Strathclyde)
Cited by 4
Related Papers
International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy
|Pharmacological Reviews|2006|1.3k
International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits.
|PubMed|2001|635
Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family
|Trends in Pharmacological Sciences|2003|412
International Union of Pharmacology. XXIV. Current Status of the Nomenclature and Properties of P2X Receptors and Their Subunits
|Pharmacological Reviews|2001|386
Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome
|Scientific Reports|2015|326